Zobrazeno 1 - 10
of 36
pro vyhledávání: '"Harika, Çelebi"'
Autor:
Gönül Çiçek Şentürk, İrfan Şencan, Murat Albayrak, Esra Saribacak Can, Harika Çelebi, Fatma Aybala Altay
Publikováno v:
Çağdaş Tıp Dergisi, Vol 6, Iss 2, Pp 147-149 (2016)
Volume: 6, Issue: 2 147-149
Çağdaş Tıp Dergisi
Volume: 6, Issue: 2 147-149
Çağdaş Tıp Dergisi
Trombositopeninin nadir bir sebebi: Leptospirozis
A rare cause of thrombocytopenia: Leptospirosis
A rare cause of thrombocytopenia: Leptospirosis
Autor:
Meltem Olga Akay, Harika Çelebi, Irfan Kuku, Ali Keskin, Anil Tombak, Yusuf Bilen, Ismet Aydogdu, Serdal Korkmaz, Omur Kayikci, Mehmet Hilmi Dogu, Emel Gürkan, Ramazan Esen, Mehmet Yilmaz, Serdar Sivgin, Rahsan Yildirim, Sibel Hacioglu, Ali Eser
Publikováno v:
Hematological Oncology. 33:192-198
In this multicenter retrospective analysis, we aimed to present clinical, laboratory and treatment results of 94 patients with Hairy cell leukemia diagnosed in 13 centers between 1990 and 2014. Sixty-six of the patients were males and 28 were females
Publikováno v:
Turkish journal of haematology : official journal of Turkish Society of Haematology. 23(2)
One of the major complications following hematopoietic stem cell transplantation (HSCT) is cytomegalovirus (CMV) infection. In our institution, three methods have been applied routinely for the diagnosis of CMV antigenemia (CMV-Ag): 1. Direct immunof
Autor:
Önder, Arslan, Hasan Şanol, Coşkun, Mutlu, Arat, Ender, Soydan, Muhit, Özcan, Günhan, Gürman, Harika, Çelebi, Taner, Demirer, Hamdi, Akan, Osnman, İlhan, Nahide, Konuk, Akın, Uysal, Meral, Berksaç, Haluk, Koç
Publikováno v:
Turkish journal of haematology : official journal of Turkish Society of Haematology. 19(3)
ABO incompatibility is not a contraindication for allogeneic bone marrow transplantation, but this procedure requires an extra effort for erythrocyte or plasma depletion in certain well established conditions. Some acute or delayed immunohematologica
Autor:
Aynur Albayrak, Esra Saribacak Can, Murat Albayrak, Vedat Aslan, Harika Çelebi, Birgül Öneç, Ipek Coban
Publikováno v:
Eurasian Journal of Medicine, Vol 43, Iss 03, Pp 192-195 (2011)
Imatinib mesylate (STI 571) is one of the fundamental chemotherapeutic agents used in the treatment of the chronic, accelerated and blastic phases of chronic myelocytic leukemia (CML), gastrointestinal stromal tumors and Philadelphia chromosome-posit
Publikováno v:
Volume: 3, Issue: 1 123-126
Journal of Clinical and Experimental Investigations
Journal of Clinical and Experimental Investigations, Vol 3, Iss 1, Pp 123-126 (2012)
Journal of Clinical and Experimental Investigations
Journal of Clinical and Experimental Investigations, Vol 3, Iss 1, Pp 123-126 (2012)
Factor XIII deficiency is a quite rare bleeding disorder in which detecting tests for coagulation are found in normal ranges. This disorder usually does not cause spontaneous bleeding but other than excessive bleeding after invasive procedures, impai
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0ea103190d792bfe8091e7aecdffa690
https://dergipark.org.tr/tr/pub/jcei/issue/9898/122460
https://dergipark.org.tr/tr/pub/jcei/issue/9898/122460
Autor:
O. Arslan, Gunhan Gurman, C Beyan, Meral Beksac, Harika Çelebi, A Yalcin, Deniz Sargin, Hamdi Akan, Pervin Topcuoglu, Osman Ilhan, Muhit Ozcan, Sevgi Kalayoglu-Besisik
Publikováno v:
Bone Marrow Transplantation. 31:897-904
Since transplantation cannot be performed immediately after the diagnosis of chronic myelogenous leukemia (CML), interferon treatment is usually required. This study aims to analyze the effects of interferon-alpha (IFN) treatment on allogeneic stem c
Autor:
C. Üstün, Onder Arslan, Meral Beksac, Taner Demirer, Hamdi Akan, E Akçağlayan, Osman Ilhan, Nahide Konuk, Akin Uysal, Mutlu Arat, Muhit Ozcan, Gunhan Gurman, Harika Çelebi, Haluk Koç
Publikováno v:
Bone Marrow Transplantation. 27:499-505
We studied the effects of recombinant human granulocyte colony-stimulating factor (G-CSF) on hematopoietic recovery and clinical outcome in patients undergoing allogeneic peripheral blood stem cell (PBSC) transplantation. Fifty-six patients with hema
Autor:
Meral Beksac, Haluk Koç, Osman Ilhan, Gunhan Gurman, Harika Çelebi, C. Üstün, O. Arslan, Akin Uysal, Mutlu Arat, Muhit Ozcan, Nahide Konuk, Hamdi Akan
Publikováno v:
Therapeutic Apheresis and Dialysis. 5:54-57
Allogeneic peripheral blood stem cell transplantation (PBSCT) is rarely applied for the treatment of severe aplastic anemia (SAA) because of questionable durability of engraftment and increased risk of graft versus host disease (GVHD). We performed a
Autor:
Meral Beksac, Taner Demirer, Hamdi Akan, Gunhan Gurman, Akin Uysal, Osman Ilhan, O. Arslan, Harika Çelebi, Yasemin Genç, Mutlu Arat, Nahide Konuk, Haluk Koç, Muhit Ozcan, Klara Dalva
Publikováno v:
Journal of Clinical Apheresis. 16:67-73
The objective of this study was to quantify subpopulations of CD34+ cells such as CD41+ and CD42+ cells that might represent megakaryocyte (MK) precursors in peripheral blood stem cell (PBSC) collections of normal, recombinant human granulocyte-colon